Tag | Content |
---|
EnhancerAtlas ID | HS040-18301 |
Organism | Homo sapiens |
Tissue/cell | Esophagus |
Coordinate | chr19:30162140-30164730 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MEF2A | MA0052.3 | chr19:30162545-30162557 | GCTAAAAATAGC | + | 6.44 | MEF2B | MA0660.1 | chr19:30162545-30162557 | GCTAAAAATAGC | + | 6.92 | MEF2C | MA0497.1 | chr19:30162543-30162558 | AAGCTAAAAATAGCA | + | 8.03 | NFE2L1 | MA0089.2 | chr19:30162847-30162862 | AGAGCTGAGTCATGC | - | 6.23 | REL | MA0101.1 | chr19:30164516-30164526 | GGAAATCCCC | - | 6.02 |
|
| Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
SE_01995 | chr19:30162190-30164011 | Aorta | SE_03500 | chr19:30162856-30163592 | Brain_Angular_Gyrus | SE_04418 | chr19:30161971-30164004 | Brain_Anterior_Caudate | SE_05104 | chr19:30161943-30175216 | Brain_Cingulate_Gyrus | SE_05992 | chr19:30161895-30175512 | Brain_Hippocampus_Middle | SE_07189 | chr19:30161916-30170161 | Brain_Hippocampus_Middle_150 | SE_08055 | chr19:30161921-30164788 | Brain_Inferior_Temporal_Lobe | SE_12389 | chr19:30161691-30165248 | CD3 | SE_15294 | chr19:30161517-30168364 | CD4_Memory_Primary_7pool | SE_16572 | chr19:30161499-30165474 | CD4_Naive_Primary_8pool | SE_18169 | chr19:30155285-30168956 | CD4p_CD25-_CD45ROp_Memory | SE_19560 | chr19:30161728-30168512 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20556 | chr19:30155335-30172521 | CD56 | SE_21321 | chr19:30161657-30165390 | CD8_Memory_7pool | SE_40973 | chr19:30161560-30165126 | Left_Ventricle | SE_41671 | chr19:30162218-30163132 | LNCaP | SE_41671 | chr19:30163219-30167352 | LNCaP | SE_42924 | chr19:30161733-30165058 | Lung | SE_48180 | chr19:30153054-30174554 | Psoas_Muscle | SE_48808 | chr19:30161040-30164995 | Right_Atrium | SE_49565 | chr19:30162474-30163503 | Right_Ventricle | SE_51595 | chr19:30160892-30165284 | Skeletal_Muscle | SE_55264 | chr19:30162098-30165400 | Thymus |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GAATTACAGG TGTGAGGCAC TGTGTCCGGC CTTCCTCCTA CCTATTTTTA TTCATAGATA 60 TAGTTCTTGA ACACTTTCAG AATGTTATGT AATTCCTGCA TAAGTGGTGT CACTTTACAT 120 ACAACATTCT ACAGGCTGTG TTTTTCCACT CCACGTTTGT TGTTTGCCGT CAGACCACAT 180 TGATCTGTAT CTCTCATTGC GTGAGTAGCC CCGGGTTTTT ATCCTTTTCC CTGCTGGTAG 240 GCATTTTGGT TGTCTCTGCT GGGCAGTCAT TGCTCTTTGT GGAATGCAGT TCTGGTTTTG 300 TCAGATTGTC CCTCAGCCAG GTACTCGGTG ATCAGTCATG GTGGGACAGG TCAGTTCTGT 360 CACTGGTAAT CCCCTAGGTT TGCAGTATAC AGCCAAGATC AGCAAGCTAA AAATAGCAGT 420 TCTTACGTAA GGTAGTGTGG GCAGCCCTTC TCAGGACACT TGTGATCTGC AGGGGCAAGT 480 GGAACGGGAC TCGAGGGCCC AGCATCTTCT GTTCTGCAAT GCATCCACCC TCACACTGGG 540 GCCCCACTCT GGCTTTCTAC TGGTGGCCAG GCTCAGAACT GCAGCTCAGT GACCCAGAAA 600 CACTATGGGT GTGATCAGCT CAGCCCCAGG CGTGCCGTGT GTACCGGAAT GCATGTGTGC 660 ACGTGGTGGT GGTGGGGCCA GCTCTCACCT CTTCCTCTGT AGAGGTAAGA GCTGAGTCAT 720 GCATGGTGGG CCTTGGGACC TGCTTGGAAC CGTGCCAAGC TACTTATGAA GCATCTAGTA 780 TGTGCTTGGC ATGGCTCCAA GAATTGTGGA CACAATGAAC AAGAAGAAGC TCCTGTTCTC 840 ATGGAGCTAA GAACTGAGCA GGGAAGCAGA AAACACACAA GCAATGAATA GACAAGCAAA 900 CAGCAGGTCC TGTTAAATCC CACAAAGAAA AACGATTGAA TCCCAGAGAA GTGGCCAGCA 960 GACCTTTTCT ACAAAGGGCC AGGTGGTGAA TATTTTAGGC TTTGTCACCA TGTAGTCCCT 1020 GTCACCAACA CTCAACTCTC CCATTGCAGT GTGGAAGCCA CCAGAGACAA TAATAAATGA 1080 ACGAATGTGG CTGTGTCCCA ATAAATCTTT AACAAAAGCA GGCTGAGGGC CGGATTTGAC 1140 TCTCAGACCT TGGATTACCA ATGCTTGTCC TGGGTGTGGG AAGAGGCTGC CTGAGCTGGG 1200 GTTGTCAGGG AGAACCCTTT CAAAAAGGAA CTGAGAACCC GTTGCAGGAA GGAGCTGACC 1260 CTGGGACAGC CTGTCTCAGG TAGGACACAA TGGCACCTTG CCACCGATAT GGTGGCGGAG 1320 TTATGTGCTG AGAAATGGGC AGGCTAGATT TGAGAGGTAA AGATGATGAG ATTTACTCAT 1380 GGCTTGAATA TTGGAGGTAC AGGAAGGGGG AGATTCAAGG ATGTGTCCTA GGTCTGGGGT 1440 TTGAACTCCT GGATGAATGG TGGTGTCACT GAAGGAGAGG AAGAGGTGCA GGTCTGCGGA 1500 GGTTTGTTGT TGGATGTGTT GAGTTTGAGG AGCTTATTAG ACAAGCAGGT GAACATCTAT 1560 GCTGACAGCC CTCCTAGAGC TTGGAGAGGC CAAGACTGGA GGCTTGGAAT GGGGAATCTA 1620 TGGCATTTAT GGGGTCTTCA AGGTCGTGAG TCTGGTGGGC TGGTGTGTGT GTGGACCAAG 1680 CAGGGGGCGC CCGGCATGAG CTCTGAGTTA GTGCTTAGTG CTTAGGGCAC CAACAGAGGG 1740 GCCTGTGTGG CCTCACACTC CACTCGGGAC GGCAGCATAG TGCGAGCTCC AGGGCCCCTG 1800 CCTCCTAGCA TCGCCTCAGT TCCCCTCCTG TAAAGTGGGG ATTCTGCCTT CTGGGGTTGG 1860 GTGGGAACTA AATGAGATAG TCACGCTTGG CTGACAGGAA GCACTCGGCG CCTGTGCTTG 1920 TGATGGTGGT GGTGACTGCT GCACTTCCTG GGTGGTTGCG TGGGTTGCAG GGCCTGTGAC 1980 AGCTTGGTTT GGTGGATGGC AGAGTCAGGG TTGGGTTGGG GGTAGAGACA CCCAGGTCTC 2040 CTGGCACAGA CCGTTCTGAT GTCCCGTTGA GGCCTGTTCC GCCCTGTTTT TCAAGGCTCC 2100 CCAGCGGGGC TGAACCTCTG CCCTCTGCTG CCCACAGTAG TAGCCGGCTC AGTAGCACTT 2160 TTTTTTTTTA AGAGATAGAA TCCACTCAGT CACCTAGCTA GAGTGTAGTG GCATGATCAT 2220 AGCTCACTGT AGCCTCAAAC TCCTGGGCTC GAGCCTCCTC TTGCCTCAGC CTTCCAAAAC 2280 GCTGGAACCA CAGGCATGAA CCGCTGCACC TGGCCTAAGT AGCACACTTT ATCACTGCCT 2340 TCCCATCCCT GTCTGGCCTC CACATCCCCT TTACTGGGAA ATCCCCCTTC CCTCCCCGTA 2400 GTTCCCTGTA CTCCCGTCTA AGGGTCAGCT TCCGAGGTGA TGCTTCTCAG TGCTGGGCAG 2460 GCCTGCGGGT TACTGTGCGT AGTCAGTGGG CTGCCTGGCA TGGTGGGTTA GTCAGTTGGG 2520 GGTGGGCAGC GTGGTTCTGA CACCCCCATG CCTGAGCCTG GACATACTCC TTGTCTGTCT 2580 CCTCCTGCAG 2590
|